$ cat ./records/gates-foundation-commits-60-million-to-monash-university-to-launc-2009.txt
Gates Foundation Commits $60 Million to Monash University to Launch World Mosquito Program
[RECORD.TXT] · cat --full
Beginning in 2009, the Gates Foundation committed $60 million to Monash University to support the World Mosquito Program (WMP), which introduces Wolbachia bacteria-carrying Aedes aegypti mosquitoes into communities to block dengue, Zika, yellow fever, and chikungunya transmission. Wolbachia prevents dengue virus replication inside the mosquito, and released populations self-sustain by displacing wild uninfected mosquitoes across breeding seasons. The programme subsequently expanded to operations in twelve countries across Asia, the Americas, and the Pacific.
Source: https://www.worldmosquitoprogram.org/en/about-us/our-story
Free forever · No ads · Solo developer
If this was worth a read, help make the next entry possible.
Every entry in this archive was researched, verified, and written by one person — for free. No corporate funding. No ad revenue. Just a developer who believes verified history should be accessible to everyone. Your donation directly funds new entries.
Crypto accepted · No subscription required
← Previous
Gates Foundation Grants $23 Million to World Cocoa Foundation to Combat Deforestation in West Africa
Next →
Gates Foundation Grants $50 Million to PSI for Voluntary Male Circumcision in Southern Africa
[CROSS_REFERENCES] · grep --category='Global Health'
Related Accomplishments
January 2026
Gates-backed World Mosquito Program reaches 16 million people protected from dengue via Wolbachia method
The World Mosquito Program — backed in part by the Gates Foundation — announced in January 2026 that its Wolbachia-infected mosquito releases had reached over 16.1 million people across multiple countries, including Colombia, Indonesia, Brazil, Sri Lanka, Fiji, Vanuatu, and Vietnam. Wolbachia-carrying Aedes aegypti mosquitoes — which block dengue, Zika, chikungunya, and yellow fever transmission — had established self-sustaining populations in treated cities without requiring ongoing releases. Gold-standard randomised trials in Indonesia showed a 77% reduction in dengue incidence. The program represented one of the largest and most cost-effective vector control deployments in history.
2025
Gates-Funded Monoclonal Antibody Shows Early Promise as a Single-Shot Malaria Shield
[ARCHIVE_FUNDING] · INDEPENDENT · NO ADS
One developer. >300 verified entries. Zero ads. Forever free.
No sponsors, no paywall, no algorithm. If this archive has been useful to you, reader support is what keeps it running.